L.M. Kohn & Company Eli Lilly & CO Transaction History

L.M. Kohn & Company

$373 Million
Q1 2025

A detailed history of L.M. Kohn & Company transactions in Eli Lilly & CO stock. As of the latest transaction made, L.M. Kohn & Company holds 2,588 shares of LLY stock, worth $1.88 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

2,588

Previous 2,547 1.61%

Holding current value

$1.88 Million

Previous $1.97 Million 8.7%

% of portfolio

0.57%

Previous 0.52%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$725.72 - $929.72 $29,754 - $38,118	41 Added 1.61%	2,588 $2.14 Million
Q4 2024 Jan 30, 2025	SELL	$727.2 - $932.06 $129,441 - $165,906	-178 Reduced 6.53%	2,547 $1.97 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $249,401 - $310,086	323 Added 13.45%	2,725 $2.41 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $152,222 - $190,898	210 Added 9.58%	2,402 $2.17 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $166,408 - $222,630	281 Added 14.7%	2,192 $1.71 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $13,129 - $15,478	-25 Reduced 1.29%	1,911 $1.11 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $47,817 - $65,923	110 Added 6.02%	1,936 $1.04 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $139,243 - $186,185	397 Added 27.78%	1,826 $856,000
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $183,582 - $215,608	591 Added 70.53%	1,429 $490,000
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $60,772 - $70,812	189 Added 29.12%	838 $306,000
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $192,415 - $219,277	649 New	649 $210,000

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $689B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L.M. Kohn & Company, based on Form 13F filings with the SEC.

News

Stay updated on L.M. Kohn & Company with notifications on news.

Account